Lumateperone, an Antipsychotic, is Tested in a Phase 3 Trial for Major Depressive Episodes in Bipolar I and II Disorders
An international team of researchers has reported positive results in a phase 3 clinical trial of a drug to treat depressive episodes in patients with bipolar I and bipolar II disorder. Read More
Two Signaling Pathways Involved in Regulating Synaptic Plasticity Suggest Novel Targets for Rapid-Acting Antidepressants
Researchers have reported progress in the important effort to explain the rapid antidepressant action of ketamine, and in so doing, have gained insights that may inform the development of other… Read More
Adding an Antibiotic Improved Brain Stimulation Results in Depression
The two prevalent forms of non-invasive brain stimulation treatment for major depressive disorder have a well-documented ability to help patients, including some who have not been helped by popular… Read More
Using Brainwave Patterns to Predict and Understand Psychiatric Disorders
Using a well-understood, inexpensive and easy-to-deploy technology called electroencephalography, or EEG, as well as related technologies that also measure the activity of cells in the brain,… Read More
Study Finds Changes in the Treatment of Bipolar Disorder Over 20 Years
A study covering the 20 years between 1997 and 2016 shows that substantial changes have occurred in the way doctors are treating outpatients diagnosed with bipolar disorder. Among a number of… Read More